Martingale Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,605
| Closed | -$335K | – | 841 |
|
|
2023
Q1 | $335K | Sell |
21,605
-18,105
| -46% | -$281K | 0.01% | 691 |
|
|
2022
Q4 | $705K | Sell |
39,710
-30,428
| -43% | -$540K | 0.01% | 554 |
|
|
2022
Q3 | $392K | Buy |
70,138
+74
| +0.1% | +$414 | 0.01% | 665 |
|
|
2022
Q2 | $274K | Buy |
70,064
+13
| +0% | +$51 | 0.01% | 751 |
|
|
2022
Q1 | $386K | Buy |
70,051
+8,200
| +13% | +$45.2K | 0.01% | 685 |
|
|
2021
Q4 | $527K | Buy |
61,851
+2,900
| +5% | +$24.7K | 0.01% | 636 |
|
|
2021
Q3 | $513K | Buy |
58,951
+39,430
| +202% | +$343K | 0.01% | 666 |
|
|
2021
Q2 | $207K | Buy |
+19,521
| New | +$207K | ﹤0.01% | 799 |
|